Who
Gregory L. Shiferman
SVP and General Counsel
Company insider
Files Form 4 as: SVP and General Counsel, Voyager Therapeutics; Officer, Sage Therapeutics.
In numbers
- Trades disclosed
- 20
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 1 Nov 2024
- Last trade
- 1 Apr 2026
- Last filed
- 3 Apr 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Apr 2026filed 3 Apr 2026 | VYGR Voyager TherapeuticsBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 1 Apr 2026filed 3 Apr 2026 | VYGR Voyager TherapeuticsBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 6 Jan 2026filed 8 Jan 2026 | VYGR Voyager Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 6 Jan 2026filed 8 Jan 2026 | VYGR Voyager Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 31 Jul 2025filed 31 Jul 2025 | Sage Therapeuticsoption or derivative | SEC FORM 4 Code D | —10,000 | filing |
| 31 Jul 2025filed 31 Jul 2025 | Sage Therapeuticsoption or derivative | SEC FORM 4 Code D | —28,000 | filing |
| 31 Jul 2025filed 31 Jul 2025 | Sage Therapeutics | SEC FORM 4 Code U | —7,215 | filing |
| 31 Jul 2025filed 31 Jul 2025 | Sage Therapeutics | SEC FORM 4 Code D | —23,735 | filing |
| 24 Jun 2025filed 26 Jun 2025 | Sage Therapeutics | SEC FORM 4 Code F | $72879 at $9.22 | filing |
| 10 Apr 2025filed 11 Apr 2025 | Sage Therapeutics | SEC FORM 4 Code A | —525 at $0.00 | filing |
| 10 Apr 2025filed 11 Apr 2025 | Sage Therapeutics | SEC FORM 4 Code F | $1,216176 at $6.91 | filing |
| 24 Mar 2025filed 26 Mar 2025 | Sage Therapeutics | SEC FORM 4 Code F | $64979 at $8.21 | filing |
| 24 Feb 2025filed 25 Feb 2025 | Sage Therapeutics | SEC FORM 4 Code F | $19K2,502 at $7.49 | filing |
| 13 Feb 2025filed 14 Feb 2025 | Sage Therapeutics | SEC FORM 4 Code F | $2,700376 at $7.18 | filing |
| 13 Feb 2025filed 14 Feb 2025 | Sage Therapeutics | SEC FORM 4 Code F | $1,802251 at $7.18 | filing |
| 16 Jan 2025filed 21 Jan 2025 | Sage Therapeuticsoption or derivative | SEC FORM 4 Code A | —28,000 at $0.00 | filing |
| 16 Jan 2025filed 21 Jan 2025 | Sage Therapeutics | SEC FORM 4 Code A | —14,000 at $0.00 | filing |
| 24 Dec 2024filed 27 Dec 2024 | Sage Therapeutics | SEC FORM 4 Code F | $43379 at $5.48 | filing |
| 1 Nov 2024filed 1 Nov 2024 | Sage Therapeuticsoption or derivative | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 1 Nov 2024filed 1 Nov 2024 | Sage Therapeutics | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.